TCL Archive In Brief: WHI Revises Protocol After Study Finds High Rate Of Endometrial Hyperplasia January 27, 1995
TCL Archive In Brief: Proposed Drug Act Revisions Would Provide Quick Approval Of “Breakthroughs,” IND_NDA Changes March 24, 1978
TCL Archive “Wild West” of Molecular Testing?: Caris Engaged in Aggressive Marketing, Improper Medicare Billing, Lawsuit Alleges August 8, 2014
TCL Archive DCE Board Approves concept For New Studies On Black, White Differences In Cancer Rates July 13, 1984
TCL Archive A Message From NCI: “We Deeply Regret The Need To Eliminate This Program.” AP4 Applicants And Corporate Partners Spent Years, Money, Before NCI Pulled The Plug On Novel Public-Private Partnerships. Von Eschenbach Called AP4 “A New Paradigm” For Drug Development. NCI Executive Committee “Prioritized” Programs. April 21, 2006
